Dr. Janet Pope: Interstitial Lung Disease and RA
Dr. Len Calabrese: Herpes Zoster
Dr. Julio Gonzalez: Radiographic Progression in Psoriatic Arthritis
Hard to read but vast DDX of granulomatous disease #ACR17 pic.twitter.com/MIjqgdaavS
— Suleman Bhana, MD (@DrBhana) November 7, 2017
Did you realize that @Twitter now allows all users to send 280-character tweets, doubling the number of allowed characters from 140? This means that you can include twice as much information in your tweets, although I don’t think longer is always better. What do you think? #ACR17
— Jonathan Hausmann MD (@hausmannMD) November 7, 2017
Great talk by Dr.Capelli. Pleasure to tweet with her earlier this year in #JCRheum . #ACR17 @EMEUNET pic.twitter.com/oN7b65mB34
— Anne Troldborg (@TroldborgAnne) November 7, 2017
Treatment strategies for sarcoidosis: Baughman Grutters lancet 2015 #ACR17 pic.twitter.com/K4C9jCxj10
— Suleman Bhana, MD (@DrBhana) November 7, 2017
Mtx is steroid sparing for acute sarcoidosis #ACR17 pic.twitter.com/guq4OPB7kV
— Christian Ammitzbøll (@cgytz) November 7, 2017
Who should have infliximab? #sarcoidosis #ACR17 pic.twitter.com/JtsKbJivfD
— Christian Ammitzbøll (@cgytz) November 7, 2017
Oral steroids >10mg/ day doubles the risk for both postoperative and prosthetic infection. No differences across anti-TNFs #ACR17
— jonathan marks (@dr_jonmarks) November 7, 2017
The use of low dose aspirin as primary prevention of CV events in RA had similar risk of major NSAID toxicity and MACE as patients not on it. A larger cohort will be needed to confirm use of low dose aspirin for primary prevention of CV events in RA, Solomon #ACR17
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
Dr David Daikh just became president of the @ACRheum. His advocacy team looks forward to a great year advancing rheumatology in the US! pic.twitter.com/dZhAyQG1c5
— Angus Worthing MD (@AngusWorthing) November 7, 2017
Always great to see my friend @_connectedcare #ACR17 pic.twitter.com/4cMa6CELuD
— Dr. Paul Sufka (@psufka) November 7, 2017
The type of Immune checkpoint inhibitors affects type and distribution of joints affected, autoantibodies may not always be positive #ACR17
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
Exercise remains the key intervention in treating fatigue. Increased activity with exercise remains safe and effective #ACR17 pic.twitter.com/1FcteberK4
— Dr. Antoni Chan (@synovialjoints) November 7, 2017
Excellent, methotrexate is not and strong trend towards being protective #ACR17 https://t.co/rYfcPLFzgh
— Richard Conway (@RichardPAConway) November 7, 2017
Talk about a team that makes a difference! https://t.co/LNF5FTzZdG
— Seth D. Ginsberg (@SethSaidSo) November 8, 2017
Radiologic or histology NSIl or OP in an young person raises questions of CTD-ILD #ACR17
— Suleman Bhana, MD (@DrBhana) November 8, 2017
Serologic risk of ILD #ACR17 pic.twitter.com/1bNgYiyE0C
— Suleman Bhana, MD (@DrBhana) November 8, 2017
SLE anD thrombocytopenia #ACR17 pic.twitter.com/h5PG3wPN8t
— dr hanady manasfi (@hanadymanasfi) November 7, 2017
Our latest review is on relapsing polychondritis: https://t.co/CbZLBmd0Eb @RheumJnl pic.twitter.com/Ig7TCVpzpM
— Rheumatology (@RheumJnl) November 7, 2017
T2T SLE#ACR17 pic.twitter.com/hb7DAuqkew
— dr hanady manasfi (@hanadymanasfi) November 7, 2017
Drink ☕️!!! Lower coffee consumption is associated with gout! #ACR17 @RheumNow #2066 pic.twitter.com/oNCSZNbNlw
— Dr. Paul Sufka (@psufka) November 7, 2017
#2127
Successful monoclonal tnfi use in sarcoidosis#ACR17 @rheumnow pic.twitter.com/cwRP8QtEXi— Julio Gonzalez (@japaoli19) November 7, 2017
Clinical utilities in bio markers of ILD #ACR17 pic.twitter.com/AhulXDqTMY
— Suleman Bhana, MD (@DrBhana) November 8, 2017
Predictors in poor outcomes in CTD ILD #ACR17 pic.twitter.com/4I2007d9H9
— Suleman Bhana, MD (@DrBhana) November 8, 2017
Treatment of ILD in myositis #ACR17 pic.twitter.com/Qf0DSV5asG
— Suleman Bhana, MD (@DrBhana) November 8, 2017
HyperCKemia: Yield for EMG + Muscle biopsy is best in patients with your age <25 years and CK>1000 #ACR17
— Suleman Bhana, MD (@DrBhana) November 8, 2017
We in rheum have a workforce shortage, and we eventually need to harness ‘augmented intelligence’ to free us up to what we do best #ACR17 pic.twitter.com/xa8JUSwEm0
— David Liew (@drdavidliew) November 7, 2017
Foods containing statins #ACR17 pic.twitter.com/EwuxRvEGKr
— Suleman Bhana, MD (@DrBhana) November 8, 2017
HCQ screening recommendations from the American Academy of ophthalmology #2016revision#ACR17 #HCQ#reviewcourse pic.twitter.com/iXwWD83OTM
— V. Ocampo D (@VOD_MD) November 4, 2017
Classification for immune mediated necrotizing myopathy (IMNM) pic.twitter.com/NUmcFanBP5
— Suleman Bhana, MD (@DrBhana) November 8, 2017
Low mean change in radiographic change after 4 years of Secukinumab treatment in AS, Braun #ACR17 pic.twitter.com/yU4mbtgpvt
— Dr. Antoni Chan (@synovialjoints) November 8, 2017
Need to understand & use proactively & constructively #ACR17 #rheum #LupusChat #spoonie pic.twitter.com/Ly3tfmNYW6
— Dr. shashank akerkar (@doctorakerkar) November 8, 2017
Ustekinumab shows clinical benefit in SLE – SRI-4 response at Wk 24 was significantly better than placebo (∆ 29%) #ACR17 late breaking abstracts https://t.co/Q1cLdTjhWv
— Hector Chinoy (@drhectorchinoy) November 8, 2017
Weight loss of 5% correlated with improved pain in knee osteoarthritis. Reasonable goal for patients. #ACR17 @RheumNow #2206 pic.twitter.com/35bJHKpP7H
— Dr. Paul Sufka (@psufka) November 7, 2017
Memorize this slide: work up for Asymptotic HyperCKemia #acr17 pic.twitter.com/AmVPB0t0s3
— Suleman Bhana, MD (@DrBhana) November 8, 2017
— Olga Petryna (@DrPetryna) November 8, 2017
Autoinflammatory disorders and their underlying genetic mutations #5T115 #acr17 @RheumNow pic.twitter.com/daYa1O0BPo
— Olga Petryna (@DrPetryna) November 8, 2017